Al-Ola A Abdallah MD (USMIRC)

9.7K posts

Al-Ola A Abdallah MD (USMIRC) banner
Al-Ola A Abdallah MD (USMIRC)

Al-Ola A Abdallah MD (USMIRC)

@Abdallah81MD

Associate Professor,Plasma Cell disorder program Director, Division of HMCT/University of Kansas Medical Center, no COI, #USMIRC Founder, #mmsm @KUMedCenter

Kansas, USA Katılım Ağustos 2018
383 Takip Edilen4.6K Takipçiler
Sabitlenmiş Tweet
Al-Ola A Abdallah MD (USMIRC)
Al-Ola A Abdallah MD (USMIRC)@Abdallah81MD·
Dr. Makhoul has always been very instrumental in my career. I really appreciate your mentorship and guidance. Thank you so much. I have learned a lot from you during my fellowship
Al-Ola A Abdallah MD (USMIRC) tweet media
English
5
2
58
0
Al-Ola A Abdallah MD (USMIRC)
🚨🔥 BIG NEWS | #ICETCongress 2026 🔥🚨 Get ready, Orlando! 🌴 📍 Orlando, FL 🗓 July 18, 2026 The National ICE-T Congress is back—bigger, bolder, and pushing the future of #CellTherapy forward 🚀 ⭐ Led by powerhouse chairs: @heMEGirl_MD @HemSandoval and ICE-T Executive Director:@kczmj ⚡ CAR-T ⚡ Bispecifics ⚡ Real-world innovation ⚡ Multidisciplinary impact This is where the future of hematology meets action. Don’t miss it. @NausheenAhmedMD Jennifer DeVore
Al-Ola A Abdallah MD (USMIRC) tweet mediaAl-Ola A Abdallah MD (USMIRC) tweet mediaAl-Ola A Abdallah MD (USMIRC) tweet media
English
0
1
1
58
Al-Ola A Abdallah MD (USMIRC) retweetledi
OncoDaily
OncoDaily@oncodaily·
𝐌𝐲𝐞𝐥𝐨 𝟐𝟎𝟐𝟔 | 𝐕𝐢𝐫𝐭𝐮𝐚𝐥 𝐆𝐥𝐨𝐛𝐚𝐥 𝐂𝐨𝐧𝐠𝐫𝐞𝐬𝐬 𝐨𝐧 𝐌𝐮𝐥𝐭𝐢𝐩𝐥𝐞 𝐌𝐲𝐞𝐥𝐨𝐦𝐚 The 4th session of Myelo 2026: Virtual Global Congress on Multiple Myeloma featured expert-led discussions from Jenny Myers Ahlstrom, Heather Cooper Ortner, @Abdallah81MD, and Shayna Sarosiek. Key topics included the future of tech-enabled advocacy, redefining patient outcomes beyond survival, evolving treatment strategies for Waldenström Macroglobulinemia, and the growing impact of BiTEs in relapsed/refractory multiple myeloma (RRMM). An engaging panel discussion closed the session, underscoring ongoing progress and shared efforts to improve outcomes in multiple myeloma care. #Cancer #Medicine #Health #Oncology #OncoDaily #MultipleMyeloma #Myelo2026
OncoDaily tweet mediaOncoDaily tweet mediaOncoDaily tweet mediaOncoDaily tweet media
English
0
1
3
165
Al-Ola A Abdallah MD (USMIRC) retweetledi
OncoDaily
OncoDaily@oncodaily·
We’re excited to announce Dr. Al-Ola Abdallah (@Abdallah81MD) as speakers at Myelo 2026, organized by OncoDaily. On this important day Al-Ola Abdallah will join global experts, advocates, and changemakers to support a worldwide conversation and collective action against multiple myeloma. 📅 April 23, 2026 🔗 Register: docs.google.com/forms/d/e/1FAI… #OncoDaily #Oncology #Cancer #Health #Medicine #MedX #MedTwitter #Myeloma
OncoDaily tweet media
English
0
1
3
255
Daniel Auclair
Daniel Auclair@AuclairDan·
Hack Alert! Colleagues have been plagued by a recent hack on X, reported it to X, had to delete their X accounts, start anew and are asking to spread the word as they are locked out of their old account. If you get a message like below do not click. This is the fourth one I got.
Daniel Auclair tweet media
English
2
0
10
2.1K
Al-Ola A Abdallah MD (USMIRC) retweetledi
Al-Ola A Abdallah MD (USMIRC)
🚨🔥 BIG NEWS | #ICETCongress 2026 🔥🚨 Get ready, Orlando! 🌴 📍 Orlando, FL 🗓 July 18, 2026 The National ICE-T Congress is back—bigger, bolder, and pushing the future of #CellTherapy forward 🚀 ⭐ Led by powerhouse chairs: @heMEGirl_MD @HemSandoval and our ICE-T Executive Director: @kczmj ⚡ CAR-T ⚡ Bispecifics ⚡ Real-world innovation ⚡ Multidisciplinary impact This is where the future of hematology meets action. Don’t miss it. @NausheenAhmedMD @KUcancercenter @USMIRCNEWS @oncodaily @MedwatchKate @US_HMC #MedEd #medtwitter
Al-Ola A Abdallah MD (USMIRC) tweet media
English
0
2
9
427
Al-Ola A Abdallah MD (USMIRC)
🧵 Cilta-cel in High-Risk Smoldering Myeloma (CAR-PRISM, Phase 2) Groundbreaking—but let’s stay critical and take a look at this closely from all angles👇 1/ 🔬 Concept shift: Treating precursor disease (HR-SMM) with CAR-T 🤯 ➡️ Aim: intercept progression, maybe even cure 💡 Rationale: ✔️ Lower tumor burden ✔️ Better T-cell fitness ✔️ Less immune exhaustion #ICE_T #MedEd #medtwitter #USMIRC @US_HMC @MedwatchKate @oncodaily @Larvol @USMIRCNEWS #mmsm #myeloma
Al-Ola A Abdallah MD (USMIRC) tweet media
English
2
2
7
558